
Personalized Medicine Biomarkers Market, By Type (Genetic Biomarkers, Protein Biomarkers, and Metabolite Biomarkers), By Application (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, and Others), By End User (Hospitals, Diagnostic Laborator
Description
Personalized medicine biomarkers market refers to the utilization of genetic information to plan the most suitable treatment for patients. Personalized medicine aims to design preventive or therapeutic products tailored to an individual's characteristics, including their predicted predisposition to illness. Biomarkers play an important role in personalized medicine as they help identify which patients are suitable for specific treatments. Biomarkers can be utilized to screen for diseases, identify the risk of developing a disease, predict the rate of disease progression, and assess the response to treatment. Increasing availability of genetic tests, growing prevalence of chronic diseases, rising focus on precision medicine, and technological advancements are some of the key factors expected to propel the growth of the global personalized medicine biomarkers market.
Market Dynamics:
Global personalized medicine biomarkers market growth is driven by several factors such as growing prevalence of chronic and life-threatening diseases worldwide, rising R&D initiatives by pharmaceutical companies, increasing application of biomarkers in drug discovery and development, growing focus on precision medicine, technological advancements in biomarker identification, and availability of genetic tests. However, high costs associated with biomarker-based tests and lack of reimbursement policies are expected to restrain the market growth. The market players have significant opportunities in developing economies owing to growing healthcare expenditure, rising awareness about personalized medicine, and increasing healthcare research grants. New product launches, collaborations between market players and research institutes, and geographical expansion strategies by companies are some key opportunities in the global personalized medicine biomarkers market.
Key Features of the Study:
Market Dynamics:
Global personalized medicine biomarkers market growth is driven by several factors such as growing prevalence of chronic and life-threatening diseases worldwide, rising R&D initiatives by pharmaceutical companies, increasing application of biomarkers in drug discovery and development, growing focus on precision medicine, technological advancements in biomarker identification, and availability of genetic tests. However, high costs associated with biomarker-based tests and lack of reimbursement policies are expected to restrain the market growth. The market players have significant opportunities in developing economies owing to growing healthcare expenditure, rising awareness about personalized medicine, and increasing healthcare research grants. New product launches, collaborations between market players and research institutes, and geographical expansion strategies by companies are some key opportunities in the global personalized medicine biomarkers market.
Key Features of the Study:
- This report provides in-depth analysis of the global personalized medicine biomarkers market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- Key companies covered as a part of this study include F Roche Diagnostics, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Siemens Healthineers, Abbott Laboratories, Merck KGaA, Genomic Health, Inc., Myriad Genetics, Inc., Foundation Medicine, Inc., Exact Sciences Corporation, Guardant Health, Inc., and Luminex Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global personalized medicine biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized medicine biomarkers market
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Genetic Biomarkers
- Protein Biomarkers
- Metabolite Biomarkers
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Diagnostic Laboratories
- Research Institutions
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Roche Diagnostics
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Siemens Healthineers
- Abbott Laboratories
- Merck KGaA
- Genomic Health, Inc.
- Myriad Genetics, Inc.
- Foundation Medicine, Inc.
- Exact Sciences Corporation
- Guardant Health, Inc.
- Luminex Corporation
Table of Contents
165 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Personalized Medicine Biomarkers Market, By Type
- Global Personalized Medicine Biomarkers Market, By Application
- Global Personalized Medicine Biomarkers Market, By End User
- Global Personalized Medicine Biomarkers Market, By Region
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
- 4. Global Personalized Medicine Biomarkers Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Genetic Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Metabolite Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 5. Global Personalized Medicine Biomarkers Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 6. Global Personalized Medicine Biomarkers Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 7. Global Personalized Medicine Biomarkers Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
- 8. Competitive Landscape
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Siemens Healthineers
- Abbott Laboratories
- Merck KGaA
- Genomic Health, Inc.
- Myriad Genetics, Inc.
- Foundation Medicine, Inc.
- Exact Sciences Corporation
- Guardant Health, Inc.
- Luminex Corporation
- 9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- 10. References and Research Methodology
- References
- Research Methodology
- About us
- *Browse 32 market data tables and 28 figures on 'Personalized Medicine Biomarkers Market' - Global forecast to 2032
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.